up to now few years, the united kingdom has witnessed a revolution in medical bodyweight‑decline treatment plans — within the introduction of semaglutide (Wegovy®) into the escalating reputation of tirzepatide (Mounjaro®). Now, An additional name is drawing interest in equally clinical and public